Hormone Replacement Therapy (HRT)

Right Decisions
TAM (Treatments and Medicines) NHS Highland
FORMULARIES
HIGHLAND FORMULARY
Back
OBSTETRICS AND GYNAECOLOGY
Hormone Replacement Therapy (HRT)

Please update your RDS mobile app to version 4.7.1

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Refer to Menopause and HRT guidance for further information, also note NICE guidance NG23 Menopause: diagnosis and management. Oral preparations are usually first-line unless not tolerated. Where patients have persistent oestrogenic side-effects, reduce dose and change preparation or move to a transdermal preparation. For patients with risk factors for venous thromboembolism or stroke consider transdermal preparations.

MHRA advice: Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping (August 2019) (www.gov.uk).

For information on HRT supply shortages see medicines shortage log (intranet access required) and shortages information.

Hormone Replacement Therapy (HRT)

For women with an intact uterus

For women without a uterus